心脏瓣膜疾患并肺动脉高压的手术处理

Clinical Experiences in Surgical Treatment of Heart Valve Disease with Pulmonary Hypertension

本文报告了我科近五年来心脏瓣膜病变合并肺动脉高压组(n=269)与肺动脉压正常组(n=67)在死亡率与围术期主要并发症方面的统计学对比。资料表明:肺动脉高压不构成手术禁忌,重症肺动脉高压对围术期的主要影响在血动力学方面,表现为术后低心输出量及恢复期慢性心功不全的发生率增加。与正常组对比肺动脉高压组室颤发生率也有统计学意义。肺动脉高压组对主要肺并发症(肺功能不全及肺感染等)影响与正常组相比不具统计学意义。

Statistical differences in mortality and incidence of perioperative complications between the cases with pulmonary hypertension (pH, group 1) and normal pulmonary pressure (group 2) are reported. The analysis shows: 1. pH in valvular diseases is not a contraindication or operation. 2. Severe pH influences on the perioperative hemodynamics, including low cardiac output and/or chronic heart failure. 3. Relation between pH and postoperative pulmonary complications is of no statistic significance.